ALK-Abello

Introduction

Global leader in allergy immunotherapy ALK is a research-based pharmaceutical company and globally active in allergy prevention, diagnosis and treatment.

Financials

Year	2019	2020	2021	2022	HY 2023
HEX	6	10	10	10	10
HES (solvability)	56,14	55,06	58,16	61,56	64,30
HER (ratio)	509,54	838,50	878,86	904,43	887,40